Quality control in the apoA-I secretory pathway: Deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions

Journal of Lipid Research

Volumn 45, Issue 7, 2004, Pages 1207-1220

  Bhat, Shaila ^a   Zabalawi, Manal ^a   Willingham, Mark C ^a   Shelness, Gregory S ^a   Thomas, Michael J ^a   Sorci Thomas, Mary G ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Aggregation; Aggresomes; Apolipoprotein A I; Endoplasmic reticulum; Golgi; High density lipoprotein; Immunofluorescence; Mutant apolipoprotein A I; Nuclear envelope; Protein secretion; Quality control pathway

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; DELETION MUTANT; ENDOPLASMIC RETICULUM; GENE MUTATION; GENE TRANSFER; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LIPID INTERACTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SECRETION; QUALITY CONTROL; TRANSGENIC MOUSE; WILD TYPE;

APOLIPOPROTEIN A-I; CELL LINE, TUMOR; CYTOSOL; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; INCLUSION BODIES; LIPOPROTEINS, HDL; PHOSPHOLIPIDS; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; SEQUENCE DELETION; TRANSFECTION;

EID: 3042651483     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300498-JLR200     Document Type: Article

References (58)

1. Higuchi, K., S. W. Law, J. M. Hoeg, U. K. Schumacher, N. Meglin, and H. B. Brewer, Jr. 1988. Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5′-flanking region of the human apoA-I gene. J. Biol. Chem. 263: 18530-18536.
2. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
3. Fielding, C.J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
4. Rigotti, A., H. E. Miettinen, and M. Krieger. 2003. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24: 357-387.
5. Schaefer, E. J. 1994. Familial lipoprotein disorders and premature coronary artery disease. Med. Clin. North Am. 78: 21-39.
6. Castelli, W. P., R.J. Garrison, P. W. F. Wilson, and S. Abbott. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. J. Am. Med. Assoc. 156: 2835-2838.
7. Hamilton, R. L., M. C. Williams, C. J. Fielding, and R. J. Havel. 1976. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J. Clin. Invest. 58: 667-680.
8. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
9. Hamilton, R. L., A. Moorehouse, and R. J. Havel. 1991. Isolation and properties of nascent lipoproteins from highly purified rat hepatocytic Golgi fractions. J. Lipid Res. 32: 529-643.
10. Rusinol, A., H. Verkade, and J. E. Vance. 1993. Assembly of rat hepatic very low density lipoproteins in the endoplasmic reticulum. J. Biol. Chem. 268: 3555-3562.
11. Banerjee, D., and C. M. Redman. 1983. Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein. J. Cell Biol. 96: 651-660.
12. LeCureux, L. W., F. J. Kezdy, and B. W. Wattenberg. 1994. The efficiency and kinetics of secretion of apolipoprotein A-I in hepatic and non-hepatic cells. Atherosclerosis. 106: 225-233.
13. Banerjee, D., T. K. Mukherjee, and C. M. Redman. 1985. Biosynthesis of high density lipoprotein by chicken liver: intracellular transport and proteolytic processing of nascent apolipoprotein A-I. J. Cell Biol. 101: 1219-1226.
14. Dixon, J. L., R. Battini, S. Ferrari, C. M. Redman, and D. Banerjee. 1989. Expression and secretion of chicken apolipoprotein AI in transfected COS cells. Biochim. Biophys. Acta. 1009: 47-53.
15. Dixon, J. L., R. Chattapadhyay, T. R. Huima, C. M. Redman, and D. Banerjee. 1992. Biosynthesis of lipoprotein: location of nascent apoA-1 and apoB in the rough endoplasmic reticulum of chicken hepatocytes. J. Cell Biol. 117: 1161-1169.
16. Howell, K. E., and G. E. Palade. 1982. Heterogeneity of lipoprotein particles in hepatic Golgi fractions. J. Cell Biol. 92: 833-845.
17. Chisholm, J. W., E. R. Burleson, G. S. Shelness, and J. S. Parks. 2002. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-1 and intracellularly assembled nascent HDL. J. Lipid Res. 43: 36-44.
18. Kiss, R. S., D. C. McManus, V. Franklin, W. L. Tan, A. McKenzie, G. Chimini, and Y. L. Marcel. 2003. The lipidation by hepatocytes of human apolipoprotein A-1 occurs by both ABCA1-dependent and -independent pathways. J. Biol. Chem. 278: 10119-10127.
19. Marcel, Y. L., and R. S. Kiss. 2003. Structure-function relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations. Curr. Opin. Lipidol. 14: 151-157.
20. Klon, A. E., J. P. Segrest, and S. C. Harvey. 2002. Comparative models for human apolipoprotein A-1 bound to lipid in discoidal high-density lipoprotein particles. Biochemistry. 41: 10895-10905.
21. Brouillette, C. G., G. M. Anantharamaiah, J. A. Engler, and D. W. Borhani. 2001. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim. Biophys. Acta. 1531: 4-46.
22. Klon, A. E., M. K. Jones, J. P. Segrest, and S. C. Harvey. 2000. Molecular belt models for the apolipoprotein A-I Paris and Milano mutations. Biophys. J. 79: 1679-1685.
23. Sorci-Thomas, M. G., and M. J. Thomas. 2002. The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc. Med. 12: 121-128.
24. Sorci-Thomas, M. G., M. Thomas, L. Curtiss, and M. Landrum. 2000. Single repeat deletion in apoA-I blocks cholesterol esterification and results in rapid catabolism of D6 and wild-type apoA-I in transgenic mice. J. Biol. Chem. 275: 12156-12163.
25. Baralle, M., and F. E. Baralle. 2000. Genetics and molecular biology. Curr. Opin. Lipidol. 11: 653-656.
26. McManus, D. C., B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel. 2001. Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia. J. Biol. Chem. 276: 21292-21302.
27. Parolini, C., G. Chiesa, Y. Zhu, T. Forte, S. Caligari, E. Gianazza, M. G. Sacco, C. R. Sirtori, and E. M. Rubin. 2003. Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion. J. Biol. Chem. 278: 4740-4746.
28. Sorci-Thomas, M. G., J. S. Parks, M. W. Kearns, G. N. Pate, C. Zhang, and M. J. Thomas. 1996. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression. J. Lipid Res. 37: 673-683.
29. Sorci-Thomas, M., M. W. Kearns, and J. P. Lee. 1993. Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. J. Biol. Chem. 268: 21403-21409.
30. Li, H. H., M.J. Thomas, W. Pan, E. Alexander, M. Samuel, and M. G. Sorci-Thomas. 2001. Preparation and incorporation of probe-labeled apoA-I for fluorescence resonance energy transfer studies of rHDL. J. Lipid Res. 42: 2084-2091.
31. Sorci-Thomas, M. G., L. Curtiss, J. S. Parks, M. J. Thomas, and M. W. Kearns. 1997. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin: cholesterol acyltransferase reactivity. J. Biol. Chem. 272: 7278-7284.
32. Sorci-Thomas, M. G., L. Curtiss, J. S. Parks, M. J. Thomas, M. W. Kearns, and M. Landrum. 1998. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin: cholesterol acyltransferase activation. J. Biol. Chem. 273: 11776-11782.
33. Ingram, M. F., and G. S. Shelness. 1997. Folding of the amino-terminal domain of apolipoprotein B initiates microsomal triglyceride transfer protein-dependent lipid transfer to nascent very low density lipoprotein. J. Biol. Chem. 272: 10279-10286.
34. Shelness, G. S., K. C. Morris-Rogers, and M. F. Ingram. 1994. Apolipoprotein B48-membrane interactions. Absence of transmembrane localization to nonhepatic cells. J. Biol. Chem. 269: 9310-9318.
35. Colvin, P., E. Moriguchi, H. Barrett, J. Parks, and L. Rudel. 1998. Production rate determines plasma concentration of large high density lipoprotein in non-human primates. J. Lipid Res. 39: 2076-2085.
36. Koritnik, D. L., and L. L. Rudel. 1983. Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzyme-linked immunosorbent assay (ELISA). J. Lipid Res. 24: 1639-1645.
37. Fiske, C.A., and Y. SubbaRow. 1925. The colorimetric determination of phosphorus. J. Biol. Chem. 66: 375-400.
38. Willingham, M. C., and I. Pastan. 1985. Immunoflourescence techniques. In An Atlas of Immunofluorescence in Cultured Cells. I. Pastan, and Mark C. Willingham, editors. Academic Press, Orlando, FL. 1-13.
39. Willingham, M. C., and I. Pastan. 1985. Morphologic methods in the study of endocytosis in cultured cells. In Endocytosis. I. Pastan and M. C. Willingham, editors. Plenum Publishing, New York. 281-321.
40. Willingham, M. C., and A. V. Rutherford. 1984. The use of the osmium-thiocarbohydrazide-osmium (OTO) and ferrocyanide-reduced osmium methods to enhance membrane contrast and preservation in cultured cells. J. Histochem. Cytochem. 32: 455-460.
41. Zannis, V. I., S. K. Karathanasis, H. T. Keutmann, G. Goldberger, and J. L. Breslow. 1983. Intracellular and extracellular processing of human apolipoprotein A-I: isoprotein 2 is a propeptide. Proc. Natl. Acad. Sci. USA. 80: 2574-2578.
42. Banerjee, D., G. Grieninger, J. L. Parkes, T. Kumar, T. K. Mukherjee, and C. M. Redman. 1986. Regulation of apo-A-I processing in cultured hepatocytes. J. Biol. Chem. 261: 9844-9849.
43. Miettinen, H. E., M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomâki, T. A. Miettinen, and K. Kontula. 1997. Apolipoprotein A-InN (Leu159→Arg) mutation affects lecithin-cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts. Arterioscler. Thromb. Vasc. Biol. 17: 3021-3032.
44. Fin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene. Arterioscler. Thromb. Vasc. Biol. 17: 83-90.
45. Johnston, J. A., C. L. Ward, and R. R. Kopito. 1998. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143: 1883-1898.
46. Garcia-Mata, R., Y. S. Gao, and E. Sztul. 2002. Hassles with taking out the garbage: aggravating aggresomes. Traffic. 3: 388-396.
47. Buckig, A., R. Tikkanen, V. Herzog, and A. Schmitz. 2002. Cytosolic and nuclear aggregation of the amyloid beta-peptide following its expression in the endoplasmic reticulum. Histochem. Cell Biol. 118: 353-360.
48. Wu, Y., I. Whitman, E. Molmenti, K. Moore, P. Hippenmeyer, and D. H. Perlmutter. 1994. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc. Natl. Acad. Sci. USA. 91: 9014-9018.
49. Ellgaard, L., M. Molinari, and A. Helenius. 1999. Setting the standards: quality, control in the secretory pathway. Science. 286: 1882-1888.
50. Kopito, R. R. 1999. Biosynthesis and degradation of CFTR. Physiol. Rev. 79: 167-173.
51. Hurtley, S. M., and A. Helenius. 1989. Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5: 277-307.
52. Klausner, R. D., and R. Sitia. 1990. Protein degradation in the endoplasmic reticulum. Cell. 62: 611-614.
53. Wickner, S., M. R. Maurizi, and S. Gottesman. 1999. Posttranslational quality control: folding, refolding, and degrading proteins. Science. 286: 1888-1893.
54. Kopito, R. R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10: 524-530.
55. Trombetta, E. S., and A. J. Parodi. 2003. Quality control and protein folding in the secretory, pathway. Annu. Rev. Cell Dev. Biol. 19: 649-676.
56. Deeb, S. S., M. C. Cheung, R. Peng, A. C. Wolf, R. Stern, J. J. Albers, and R. H. Knopp. 1991. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. J. Biol. Chem. 266: 13654-13660.
57. Milano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J. Clin. Invest. 66: 901-907.
58. Milano mutant - the Limone sul Garda Study. Circulation. 103: 1949-1954.